{"id":"cysticide","rwe":[],"tags":[],"phase":"phase_1","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Disease of liver","Heart disease","Liver function tests abnormal","Ocular Cysticercosis","Seizure disorder"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"active","trials":["NCT04635553","NCT00507221","NCT05323396","NCT01260012","NCT01288872","NCT03799510","NCT00403611","NCT02769013","NCT02162875","NCT03383523","NCT02878564","NCT01459146","NCT03893097","NCT01050374","NCT00817713","NCT02734186","NCT01154907","NCT02366884","NCT04115072","NCT05350462","NCT02144389","NCT05354258","NCT00441285","NCT06698510","NCT00215267","NCT02315352","NCT06182176","NCT00231322","NCT01541631","NCT00870649","NCT06565507","NCT03640377","NCT01558336","NCT00713999","NCT00347113","NCT07074444","NCT01901484","NCT03437447","NCT02271984","NCT04679831","NCT04314037","NCT00486863","NCT02612896","NCT03779347","NCT01050517","NCT01054651","NCT03845140","NCT06376396","NCT02806232","NCT03133832"],"aliases":["PZQ","Praziquantel"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"","brandName":"Cysticide","companyId":"merck-kgaa-darmstadt-germany","ecosystem":[],"mechanism":{"target":"Bile salt export pump, Glutathione S-transferase class-mu 26 kDa isozyme, High voltage-activated calcium channel beta subunit CavB1","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"biosimilars":[],"companyName":"Merck KGaA, Darmstadt, Germany","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Cysticide","indications":{"approved":[{"name":"Clonorchiasis due to C. Sinensis","diseaseId":"clonorchiasis-due-to-c.-sinensis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Infection by Schistosoma","diseaseId":"infection-by-schistosoma","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Opisthorchiasis","diseaseId":"opisthorchiasis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Schistosomiasis due to S. Haematobium","diseaseId":"schistosomiasis-due-to-s.-haematobium","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Schistosomiasis due to S. Japonicum","diseaseId":"schistosomiasis-due-to-s.-japonicum","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Schistosomiasis due to S. Mansoni","diseaseId":"schistosomiasis-due-to-s.-mansoni","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Schistosomiasis due to S. Mekongi","diseaseId":"schistosomiasis-due-to-s.-mekongi","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04635553","phase":"N/A","title":"Prevalence of Potential Schistosome Hybrids and Their Invasive Capacity Under Praziquantel Pressure in Northern Senegal","status":"UNKNOWN","sponsor":"Institut de Recherche pour le Developpement","isPivotal":false,"enrollment":250,"indication":"Schistosomiasis","completionDate":"2022-12-31"},{"nctId":"NCT00507221","phase":"NA","title":"Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression","status":"COMPLETED","sponsor":"University of Washington","isPivotal":false,"enrollment":948,"indication":"HIV Infections, Helminthiasis","completionDate":"2011-10"},{"nctId":"NCT05323396","phase":"NA","title":"Impact of Parasitic Infections on Intestinal Epithelial Barrier and Immune Activation Among Persons Living With HIV in Lilongwe, Malawi","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","isPivotal":false,"enrollment":120,"indication":"HIV Coinfection","completionDate":"2023-08-04"},{"nctId":"NCT01260012","phase":"NA","title":"Study on the Role of Antioxidant Micronutrients on the Reversal of Schistosomal Peri-portal Fibrosis of the Liver.","status":"UNKNOWN","sponsor":"Addis Ababa University","isPivotal":false,"enrollment":414,"indication":"Schistosomiasis, Liver Fibrosis","completionDate":"2015-12"},{"nctId":"NCT01288872","phase":"Phase 1","title":"Praziquantel Pharmacokinetics in Pregnancy and During Lactation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":47,"indication":"Schistosomiasis","completionDate":"2013-08"},{"nctId":"NCT03799510","phase":"Phase 2","title":"Safety and Immunogenicity Evaluation of the Vaccine Candidate Sm14 Against Schistosomiasis in Senegalese School Children Healthy or Infected With S. Mansoni and/or S. Haematobium. A Comparative, Rando","status":"COMPLETED","sponsor":"Oswaldo Cruz Foundation","isPivotal":false,"enrollment":95,"indication":"Schistosomiasis","completionDate":"2019-08-07"},{"nctId":"NCT00403611","phase":"Phase 4","title":"Evaluation of Praziquantel Dosage for Treatment of Schistosomiasis in Highly Endemic Areas of Northeastern Brazil","status":"COMPLETED","sponsor":"Oswaldo Cruz Foundation","isPivotal":false,"enrollment":196,"indication":"Schistosomiasis Mansoni","completionDate":"2008-05"},{"nctId":"NCT02769013","phase":"N/A","title":"Assessing the Effect of Neglected Tropical Diseases on Plasmodium Falciparum Transmission in an Area of Co-endemicity","status":"COMPLETED","sponsor":"University Hospital Tuebingen","isPivotal":false,"enrollment":380,"indication":"Malaria Transmission","completionDate":"2020-10"},{"nctId":"NCT02162875","phase":"NA","title":"Parasitologic Impact of Different Mass Drug Administration Strategies Against Schistosoma Mansoni in Endemic Areas of Mwanza Region, Tanzania, Where Prevalence is 25% or Above","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","isPivotal":false,"enrollment":37500,"indication":"Schistosoma Mansoni","completionDate":"2017-01"},{"nctId":"NCT03383523","phase":"Phase 1","title":"Phase1,Randomized,Open-Label,Parallel-Group,Relative Bioavailability Study to Investigate PK,Including Food Effect,Safety and Tolerability of Single Doses of New Immediate Release Tablet Formulations ","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","isPivotal":false,"enrollment":77,"indication":"Filariasis","completionDate":"2018-03-26"},{"nctId":"NCT02878564","phase":"Phase 4","title":"Effect of Schistosomiasis Mansoni and Its Treatment on HIV Susceptibility and Female Genital Immunology","status":"COMPLETED","sponsor":"University of Toronto","isPivotal":false,"enrollment":34,"indication":"Schistosomiasis Mansoni, HIV","completionDate":"2016-10"},{"nctId":"NCT01459146","phase":"Phase 4","title":"The Impact of Intermittent Preventive Malaria Treatment With Artemisinin Combination Therapy (ACT) on Hemoglobin, Malaria, Schistosomiasis, and School Attention Among Primary Schoolchildren in the Kas","status":"UNKNOWN","sponsor":"Navrongo Health Research Centre, Ghana","isPivotal":false,"enrollment":345,"indication":"Malaria, Schistosomiasis","completionDate":"2012-11"},{"nctId":"NCT03893097","phase":"Phase 3","title":"A Proof-of-concept Trial to Evaluate Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","isPivotal":true,"enrollment":726,"indication":"Schistosoma Haematobium, Schistosoma Mansoni","completionDate":"2021-03-04"},{"nctId":"NCT01050374","phase":"NA","title":"Gaps in Helminth Control: Safety and Efficacy of Drug Combinations. Praziquantel Study","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","isPivotal":false,"enrollment":650,"indication":"Parasitic Diseases","completionDate":"2008-10"},{"nctId":"NCT00817713","phase":"NA","title":"Can Anthelminthic Treatment Delay the Progression of HIV? Randomised Open-label Trial Testing Presumptive Anthelminthic Treatment on Progression of HIV in ART-naïve HIV-positive Patients in a Rural Af","status":"TERMINATED","sponsor":"Swiss Tropical & Public Health Institute","isPivotal":false,"enrollment":295,"indication":"HIV Infections, Helminthiasis","completionDate":"2010-09"},{"nctId":"NCT02734186","phase":"Phase 4","title":"Effect of Concomitant Mansonella Perstans Microfilaremia on Immune Responses Following Single Dose Praziquantel in Subjects With Schistosomiasis: A Pilot Study","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":0,"indication":"Schistosomiasis","completionDate":"2018-12-14"},{"nctId":"NCT01154907","phase":"N/A","title":"Prevention of HIV and Improved Diagnosis of Adolescent Genital Disease in Bilharzia Endemic KwaZulu-Natal, South Africa","status":"UNKNOWN","sponsor":"Oslo University Hospital","isPivotal":false,"enrollment":6500,"indication":"Uro-genital Schistosomiasis","completionDate":"2021-12"},{"nctId":"NCT02366884","phase":"Phase 2","title":"Atavistic Chemotherapy and Immunotherapy in Advanced, Metastatic, and Otherwise Incurable and Lethal Cancers Under Conventional Treatments","status":"UNKNOWN","sponsor":"Dr. Frank Arguello Cancer Clinic","isPivotal":false,"enrollment":250,"indication":"Neoplasms","completionDate":"2023-12-31"},{"nctId":"NCT04115072","phase":"Phase 2","title":"Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study","status":"COMPLETED","sponsor":"Regionshospital Nordjylland","isPivotal":true,"enrollment":116,"indication":"Schistosomiasis","completionDate":"2020-02-21"},{"nctId":"NCT05350462","phase":"N/A","title":"ADOPT - Community Intervention: Social Science Research Study to Support the Adoption of Levo-Praziquantel (L-PZQ) for the Treatment of Schistosomiasis in Pre-school Aged Children in Côte d'Ivoire, Ke","status":"UNKNOWN","sponsor":"Technical University of Munich","isPivotal":false,"enrollment":225,"indication":"Schistosomiasis in Children, Social Acceptance","completionDate":"2025-12-31"},{"nctId":"NCT02144389","phase":"NA","title":"Effects of Arachidonic Acid Supplementation on Schistosomiasis Mansoni Infection in Egyptian School Children","status":"COMPLETED","sponsor":"dsm-firmenich Switzerland AG","isPivotal":false,"enrollment":335,"indication":"Schistosomiasis, Bilharzia","completionDate":"2014-01"},{"nctId":"NCT05354258","phase":"NA","title":"Feasibility and Effectiveness of Delivering Mass Drug Administration for Helminths Through the Seasonal Malaria Chemoprevention (SMC) Platform in a West African Paediatric Population","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","isPivotal":false,"enrollment":600,"indication":"Malaria, Soil Transmitted Helminths","completionDate":"2023-09"},{"nctId":"NCT00441285","phase":"Phase 2","title":"Antiparasitic Therapy for Neurocysticercosis: Phase II/III Study on Safety and Efficacy of Combined Treatment With Praziquantel and Albendazole","status":"COMPLETED","sponsor":"Universidad Peruana Cayetano Heredia","isPivotal":true,"enrollment":156,"indication":"Neurocysticercosis, Epilepsy","completionDate":"2013-09"},{"nctId":"NCT06698510","phase":"N/A","title":"Arpraziquantel for Schistosomiasis Control in Preschool-aged Children in Endemic Areas in Kenya and Côte d'Ivoire: A Small-scale Public Health Intervention Study Arpraziquantel for Schistosomiasis Con","status":"RECRUITING","sponsor":"Peter Steinmann","isPivotal":false,"enrollment":18500,"indication":"Schistosomiasis","completionDate":"2026-03"},{"nctId":"NCT00215267","phase":"NA","title":"The Effect of One Versus Two Praziquantel Treatments on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria in Uganda","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","isPivotal":false,"enrollment":540,"indication":"Schistosomiasis, Malaria","completionDate":"2007-10"},{"nctId":"NCT02315352","phase":"Phase 1","title":"Randomized, Single Blind, Cross-over Study to Evaluate the Palatability of New Orally Disintegrating Tablets of PZQ and L-PZQ Versus Current PZQ Tablets in African Children Age 6-11 Years","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","isPivotal":false,"enrollment":48,"indication":"Healthy","completionDate":"2015-05"},{"nctId":"NCT06182176","phase":"NA","title":"Evaluating the Effectiveness and Cost-effectiveness of Integrating Mass Drug Administration for Helminth Control With Seasonal Malaria Chemoprevention in Ghanaian Children","status":"UNKNOWN","sponsor":"London School of Hygiene and Tropical Medicine","isPivotal":false,"enrollment":1200,"indication":"Malaria, Soil Transmitted Helminths","completionDate":"2026-01-12"},{"nctId":"NCT00231322","phase":"NA","title":"The Influence of Transmission Season on Outcome of Schistosoma Haematobium Infection Treatment Among School Children in Urban and Peri-Urban Areas of Maputo and Matola, Mozambique","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","isPivotal":false,"enrollment":520,"indication":"Hematuria, Hydronephrosis","completionDate":"2006-03"},{"nctId":"NCT01541631","phase":"NA","title":"Epidemiology of Human Immunodeficiency Virus (HIV-1) and Schistosoma Mansoni Co-infections and Its Impact on Anthelminthic Treatment Outcome Among HIV-1 Infected Individuals in Fishing Communities in ","status":"UNKNOWN","sponsor":"Catholic University of Health and Allied Sciences","isPivotal":false,"enrollment":2000,"indication":"Anemia, Intestinal Helminthiasis","completionDate":"2013-06"},{"nctId":"NCT00870649","phase":"Phase 3","title":"Efficacy and Safety Evaluation of the Therapeutic Vaccine Candidate Sh28GST in Association With Praziquantel (PZQ) for Prevention of Clinical and Parasitological Recurrences of S. Haematobium Infectio","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","isPivotal":true,"enrollment":250,"indication":"Urinary Schistosomiasis, Schistosoma Haematobium","completionDate":"2012-12"},{"nctId":"NCT06565507","phase":"Phase 2","title":"A Double-blind Multicenter, Randomized Controlled Trial of Single and Multiple Dose Regimens of Oxfendazole for Mild (One or Two Lesions) Parenchymal Brain Cysticercosis, With an Open Comparison Group","status":"NOT_YET_RECRUITING","sponsor":"Universidad Peruana Cayetano Heredia","isPivotal":true,"enrollment":544,"indication":"Brain Cysticercosis","completionDate":"2028-12-30"},{"nctId":"NCT03640377","phase":"Phase 2","title":"Phase II PK/PD Driven Dose Finding Trial of Praziquantel in Children Under Four","status":"UNKNOWN","sponsor":"Rhode Island Hospital","isPivotal":false,"enrollment":600,"indication":"Schistosomiasis, Schistosomiasis Mansoni","completionDate":"2022-12-31"},{"nctId":"NCT01558336","phase":"Phase 3","title":"Schistosoma Haematobium Infections Among Schoolchildren in Central Sudan One Year After Treatment With Praziquantel","status":"COMPLETED","sponsor":"University of Khartoum","isPivotal":true,"enrollment":520,"indication":"Schistosomiasis","completionDate":"2012-09"},{"nctId":"NCT00713999","phase":"NA","title":"Study of Reproductive Health in Rural Madagascar With Emphasis on Urogenital Schistosomiasis and Sexually Transmitted Infections","status":"COMPLETED","sponsor":"University of Aarhus","isPivotal":false,"enrollment":680,"indication":"Sexually Transmitted Infections, Schistosoma Haematobium","completionDate":"2003-09"},{"nctId":"NCT00347113","phase":"NA","title":"The Effect of Schistosome and Soil-transmitted Helminth Infections on Malaria,Infection, Morbidity and Antibody Response Among School and Pre-school Children in Mwanza, Tanzania","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","isPivotal":false,"enrollment":620,"indication":"Anaemia, Malaria","completionDate":"2011-01"},{"nctId":"NCT07074444","phase":"Phase 4","title":"Albendazole, Tribendimidine, and Praziquantel for Clonorchiasis in Guangxi: A Randomized Controlled Trial Comparing Efficacy and Safety","status":"RECRUITING","sponsor":"First Affiliated Hospital of Guangxi Medical University","isPivotal":false,"enrollment":318,"indication":"Clonorchiasis","completionDate":"2026-12-31"},{"nctId":"NCT01901484","phase":"Phase 2","title":"Intestinal Schistosomiasis in Children Aged 1-5 Years,Morbidity Assessment and the Effect of Praziquantel on Morbidity; Along Lake Victoria Shorelines.","status":"COMPLETED","sponsor":"Makerere University","isPivotal":false,"enrollment":800,"indication":"Intestinal Schistosomiasis","completionDate":"2014-02"},{"nctId":"NCT03437447","phase":"Phase 1","title":"A Phase I, Open-label, Randomized, Three-period, Crossover, Partial Replicated, Reference-scaled, Single Center Trial to Assess the Bioequivalence of a Single Oral Dose of 1200 mg of the New Cisticid ","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","isPivotal":false,"enrollment":60,"indication":"Healthy","completionDate":"2018-07-06"},{"nctId":"NCT02271984","phase":"Phase 1","title":"A Phase I, Open-Label, Randomized, Single Dose, Five Period, Crossover, Single Center Trial To Assess The Relative Bioavailability Of The 150 mg ODT Formulation Of L PZQ (MSC2499550A) Versus The Curre","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","isPivotal":false,"enrollment":36,"indication":"Healthy","completionDate":"2014-12-31"},{"nctId":"NCT04679831","phase":"Phase 2","title":"Clinical Evaluation of Ujiplus®, a Porridge Snack With Deworming Properties for Activity Against Schistosoma Mansoni","status":"COMPLETED","sponsor":"Kenya Medical Research Institute","isPivotal":true,"enrollment":400,"indication":"Schistosoma Mansoni","completionDate":"2022-03-30"},{"nctId":"NCT04314037","phase":"Phase 1","title":"A Phase I, Open-label, Randomized, Four-period, Crossover, Fully Replicated, Reference-scaled, Single Center Study to Assess the Bioequivalence of a Single Oral Dose of 1200 mg of the Coated Cesol Tab","status":"COMPLETED","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","isPivotal":false,"enrollment":36,"indication":"Healthy","completionDate":"2020-07-30"},{"nctId":"NCT00486863","phase":"Phase 2","title":"S. Japonicum and Pregnancy Outcomes: A Randomized, Double Blind, Placebo Controlled Trial (RCT)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","isPivotal":false,"enrollment":370,"indication":"Schistosomiasis","completionDate":"2012-11"},{"nctId":"NCT02612896","phase":"NA","title":"Taenia Solium Elimination Versus Control: What is the Best Way Forward for Sub-Saharan Africa?","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","isPivotal":false,"enrollment":2900,"indication":"Taenia Solium Infection","completionDate":"2022-02"},{"nctId":"NCT03779347","phase":"Phase 3","title":"Prospective, Observational Study to Assess the Performance of CAA Measurement as a Diagnostic Tool for the Detection of Schistosoma Haematobium Infections in Pregnant Women and Their Newborn and Child","status":"UNKNOWN","sponsor":"Centre de Recherche Médicale de Lambaréné","isPivotal":true,"enrollment":100,"indication":"Schistosomiasis Hematobium, Diagnostic","completionDate":"2022-05-01"},{"nctId":"NCT01050517","phase":"NA","title":"Gaps in Helminth Control: Safety and Efficacy of Drug Combinations Against Triple Infections","status":"COMPLETED","sponsor":"DBL -Institute for Health Research and Development","isPivotal":false,"enrollment":250,"indication":"Parasitic Diseases","completionDate":"2007-12"},{"nctId":"NCT01054651","phase":"Phase 3","title":"Open-label, Randomized Clinical Trial in Kenya to Determine the Effectiveness of Artesunate + Sulfamethoxypyrazine/Pyrimethamine Vs. Praziquantel in the Treatment of S. Mansoni in Children","status":"COMPLETED","sponsor":"Kenya Medical Research Institute","isPivotal":true,"enrollment":212,"indication":"Schistosoma Mansoni","completionDate":"2009-12"},{"nctId":"NCT03845140","phase":"Phase 3","title":"An Open Label, Phase III Efficacy and Safety Study of L-PZQ ODT in Schistosoma Infected Children 3 Months to 6 Years of Age, Including a 2:1 Randomized, Controlled Cohort of Schistosoma Mansoni Infect","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","isPivotal":true,"enrollment":288,"indication":"Schistosomiasis","completionDate":"2021-10-11"},{"nctId":"NCT06376396","phase":"Phase 4","title":"Assessment of Combined Antiparasitic Drugs Praziquantel and Albendazole Versus Albendazole Alone in the Treatment of Active Parenchymal Neurocysticercosis in Tanzania and Zambia","status":"NOT_YET_RECRUITING","sponsor":"R-Evolution Worldwide S.r.l. Impresa Sociale","isPivotal":false,"enrollment":300,"indication":"Neurocysticercosis","completionDate":"2026-12"},{"nctId":"NCT02806232","phase":"Phase 2","title":"Open-label, Dose-finding, 2-parts, Efficacy Phase II Study With Three Formulations (Racemate Raziquantel Commercial Oral Tablets, New Oral Disintegrating Tablets of Racemate Praziquantel and L-praziqu","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","isPivotal":false,"enrollment":444,"indication":"Schistosomiasis","completionDate":"2018-11-17"},{"nctId":"NCT03133832","phase":"Phase 3","title":"Efficacy of Chinese-made Versus WHO-PQ Praziquantel for Treatment of Schistosoma Haematobium in Zanzibar: a Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Jiangsu Institute of Parasitic Diseases","isPivotal":true,"enrollment":120,"indication":"Schistosomiasis Haematobia","completionDate":"2017-07-10"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Infectious Disease"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":1},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}